Keep abreast of the latest news and trends in your industry. Browse through 5.6 million articles from over 1,300 periodicals.
Issue Date:
08/01/2002
In This Issue
|
1-10 (of 19) related articles
Items per page
| |
|
1. Preventing pressure ulcers.
(Horizons).
Nurses in many types of practice settings are concerned with preventing pressure ulcers. However, the most effective methods of doing so remain elusive. Nurse researchers ... (PERIODICAL ARTICLE)
2. Community rehabilitation after severe TBI.
(Horizons).
Rehabilitation following severe traumatic brain injury (TBI) is clearly important, but the best types of programs and their timing remain unanswered questions for healthcare professionals. (PERIODICAL ARTICLE)
3. Marijuana use. (Horizons).
There is an ongoing debate about marijuana laws and the therapeutic benefit of cannabis for symptom management in several neurological conditions such as epilepsy and ... (PERIODICAL ARTICLE)
4. Preventing Alzheimer's disease.
(Horizons).
Taking folic acid-containing vitamin supplements appears to be one way to prevent dementia, but patients and healthcare providers wonder what else, if anything, can be ... (PERIODICAL ARTICLE)
5. Prevention of ischemic stroke and dementia.
(Horizons).
There has been much interest in the past few years in the role of folic acid in lowering homocysteine levels to prevent cardiovascular disease, stroke, ... (PERIODICAL ARTICLE)
6. Diphenhydramine may cause cognitive decline.
(Pharmacology Update).
Diphenhydramine is commonly used to promote sleep and is largely considered safe by most clinicians. However, a recent report from Yale University suggests that elderly ... (PERIODICAL ARTICLE)
7. Ecstasy and Parkinson's disease. (Pharmacology
Update).
Reuters Medical News released a case report of interest to those suffering from Parkinson's disease. In this report, dramatic pictures are shown of a patient ... (PERIODICAL ARTICLE)
8. Treating fatigue in MS. (Pharmacology
Update).
Those who care for persons with MS are well aware of the common complaint of fatigue. Drug treatment at best has been minimally effective with ... (PERIODICAL ARTICLE)
9. Magnesium and stroke recovery. (Pharmacology
Update).
The advent of thrombolytic therapy for acute stroke management has offered new hope for stroke victims. However, only a small number of patients are eligible ... (PERIODICAL ARTICLE)
10. New interferon approved for MS. (Pharmacology
Update).
Rebif, an interferon beta-1a product, was recently approved for use in the United States by the Food and Drug Administration (FDA) for treatment of relapsing ... (PERIODICAL ARTICLE) | |
|
1-10 (of 19) related articles
Items per page
1-10 (of 19) related articles
|
2008
Sponsored Links
Site Map | Contact Us | FAQs | About Us | Media Kit | Reprints | RSS Directory | Sign Up for Free Newsletters | Disclosure Policy
Copyright © 1999 - 2008 AllBusiness.com, Inc. All rights reserved.
No part of this content or the data or information included therein may be reproduced,
republished or redistributed without the prior written consent of AllBusiness.com.
Use of this site is governed by our Copyright and Intellectual Property Policy, Terms of Use Agreement and Privacy Policy.
© Copyright 2008 The Gale Group, Inc. All rights reserved.
You may not repost, republish, reproduce, package and/or redistribute the content of this page,
in whole or in part, without the written permission of the copyright holder.
You may not repost, republish, reproduce, package and/or redistribute the content of this page,
in whole or in part, without the written permission of the copyright holder.
Get In-Depth Company Information from Hoover's | Buy a D&B Credit Report | What is in Your Company's D&B Credit Report? | Article Archives
Online Business Database | Online Business Information | Email Marketing Lists | Sales and Marketing Solutions | Business Mailing Lists
Online Business Database | Online Business Information | Email Marketing Lists | Sales and Marketing Solutions | Business Mailing Lists
Information and opinions on AllBusiness.com solely represent the thoughts and opinions of the authors and are not endorsed by, or reflect the beliefs of,
AllBusiness.com, its parent company D&B, and its affiliates.
AllBusiness.com, its parent company D&B, and its affiliates.
